Aurora Cannabis Has Been Granted Two Licenses By The Federal Institute For Drugs And Medical Devices Under Germany's New Medical Cannabis Act For Continued Domestic Cultivation, Which Has Been Underway For Two Years Now
$ACB
Medicinal Chemicals and Botanical Products
Health Care
Under the new license, Aurora may also cultivate an approved additional product, and plans to expand their offerings to the rapidly growing German patient base. Aurora will also receive a dedicated R&D license, allowing for the trial of up to seven additional novel cultivars at the company's local EU GMP facility in Leuna, Germany.